Bangalore Pharma Formulations Private Limited
About Bangalore Pharma Formulations Private Limited
Data last updated:
Bangalore Pharma Formulations Private Limited is a private limited company based in Kannur, Kerala, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 17 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2006PTC019217. Its GSTIN is 32AACCB9963A1ZY (Kerala).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23.25 Lakh. It is led by directors including Rameshkumar Thinakkal Kizahaparambil (Managing Director) and Shajan Raphel Mekkattuparambil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tv 33/221 – 222 Al – Falah Complex Nethaji Road, Kannur, Kerala, India – 670001.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.59 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹33,253 (net margin -1%) and EBITDA of -₹31,206 (EBITDA margin -0.9%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Bangalore Pharma Formulations has one previous CIN (Corporate Identification Number): U00304KL2006PTC019217. The current CIN is U24232KL2006PTC019217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KL2006PTC019217 | Current |
| U00304KL2006PTC019217 | Previous |
Contact details
Bangalore Pharma Formulations Private Limited's registered office is in Kannur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTv 33/221 – 222 Al – Falah Complex Nethaji Road, Kannur, Kerala, India – 670001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Bangalore Pharma Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bangalore Pharma Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bangalore Pharma Formulations Private Limited, buy the company report.
Financials of Bangalore Pharma Formulations Private Limited
FY 2025 filings availableBangalore Pharma Formulations Private Limited reported revenue of ₹34.59 Lakh (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 7% fall in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹31,206 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹33,253 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bangalore Pharma Formulations Private Limited, buy the company report.
Board of directors of Bangalore Pharma Formulations Private Limited
Bangalore Pharma Formulations has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shajan Raphel Mekkattuparambil | Director | 31 Dec 2018 | 7 Years 10 Months | Current |
| Sudhakar Viswanathan | Director | 31 Dec 2018 | 7 Years 10 Months | Current |
| Cyriac Cherian Kappen | Director | 31 Dec 2018 | 7 Years 10 Months | Current |
| Rameshkumar Thinakkal Kizahaparambil Also directs: Qmar Lifesciences LLP, Pharmia Bio Genesis Private Limited, Kanhangad Links Private Limited and 3 more | Managing Director | 21 Mar 2007 | 19 Years 7 Months | Current |
Peer comparison
Bangalore Pharma Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Choudhari Drug Distributors Private Limited | ₹34.87 Lakh (FY 2021) | -66.0% | Belgaum, Karnataka, India | |||
| Nelon Pharmaceuticals Private Limited | ₹34.66 Lakh (FY 2024) | Kurukshetra, Haryana, India | ||||
| Bangalore Pharma Formulations Private Limitedthis company | ₹34.59 Lakh (FY 2025) | -₹33,253 | -1% | -7.0% | Kannur, Kerala, India | |
| Gurshyam Formulations Private Limited | ₹34.33 Lakh (FY 2024) | -37.0% | Saharanpur, Uttar Pradesh, India |
To see the full peer comparison of Bangalore Pharma Formulations Private Limited, buy the company report.
Auditor
Bangalore Pharma Formulations Private Limited is audited by THOMAS & THOMAS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THOMAS & THOMAS | FY 2017 | 004396S |
Shareholding
The shareholding of Bangalore Pharma Formulations Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Bangalore Pharma Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bangalore Pharma Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bangalore Pharma Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bangalore Pharma Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCB9963A1ZY | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bangalore Pharma Formulations Private Limited, buy the company report.
Recent activity
Bangalore Pharma Formulations Private Limited has 13 board changes on record since 2007: 4 appointments and 9 cessations. The latest: Cyriac Cherian Kappen ceased to be Additional Director on 30 Sep 2019.
4 earlier events are in the company report.
Frequently asked questions
Bangalore Pharma Formulations is an active private limited company based in Kannur, Kerala, India. The company works in other wholesale, within the trading industry. It was incorporated on 17 February 2006 (20+ years old) and is registered under CIN U24232KL2006PTC019217.
Bangalore Pharma Formulations has 4 current directors:
- Rameshkumar Thinakkal Kizahaparambil - Managing Director
- Shajan Raphel Mekkattuparambil - Director
- Sudhakar Viswanathan - Director
- Cyriac Cherian Kappen - Director
The latest financial statements of Bangalore Pharma Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bangalore Pharma Formulations is 32AACCB9963A1ZY, registered in Kerala.
The CIN (Corporate Identification Number) of Bangalore Pharma Formulations is U24232KL2006PTC019217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bangalore Pharma Formulations was incorporated on 17 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Bangalore Pharma Formulations by revenue are Choudhari Drug Distributors Private Limited, Nelon Pharmaceuticals Private Limited, Gurshyam Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Cyriac Cherian Kappen ceased to be Additional Director on 30 Sep 2019. Shajan Raphel Mekkattuparambil ceased to be Additional Director on 30 Sep 2019. Sudhakar Viswanathan ceased to be Additional Director on 30 Sep 2019. Bangalore Pharma Formulations has 13 board changes on record in total.
The registered office of Bangalore Pharma Formulations is at Tv 33221 – 222 Al – Falah Complex Nethaji Road, Kannur, Kerala, India – 670001.
Bangalore Pharma Formulations operates in the trading industry, in the other wholesale segment.
The compliance status of Bangalore Pharma Formulations is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
